NCT06563674 Acceptance-based Healthy Lifestyles Program for Patients With Pneumoconiosis
| NCT ID | NCT06563674 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Pneumoconiosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-11-01 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Symptoms, such as cough and shortness of breath, are common among patients with pneumoconiosis. Depression and anxiety can be elicited by the symptoms, while avoidance of daily activities is believed to reduce trigger of symptoms. The lung function is then declined and the risk of having stroke and heart failure is increased. The objectives of this 2-arm waitlist pilot randomized controlled trial are to test the effects and feasibility of an acceptance-based educational program among patients with pneumoconiosis. 80 participants will be recruited from community centers and randomly assigned to intervention group or waitlist-control group in a ratio of 1:1. The 6-week group-based educational program will be provided to the intervention group first, then the waitlist-control group. The program consists of 4 sessions integrated with acceptance components and care of pneumoconiosis. Their psychological health, healthy lifestyles, and cardiometabolic profiles will be assessed at baseline, week 6, and week 14. Data will be analyzed using a statistical package. The feasibility of the program will be evaluated by interview. The findings of this study can inform the integration of acceptance-based intervention into pneumoconiosis management in Hong Kong, and future study on chronic progressive lung diseases.
Eligibility Criteria
Inclusion Criteria: 1. Ethnic Chinese who is able read and speak Chinese. 2. Adults aged 18 or over. 3. Taking compensation for pneumoconiosis. Exclusion Criteria: 1. Those who have mental, visual, hearing, or cognitive impairments with regular medical follow-ups and treatment. 2. Those who are unable to give written consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06563674 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pneumoconiosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06563674 currently recruiting?
Yes, NCT06563674 is actively recruiting participants. Contact the research team at hltam@cuhk.edu.hk for enrollment information.
Where is the NCT06563674 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06563674 clinical trial?
NCT06563674 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 80 participants.